Minkyoung Yoo, Richard Nelson, Maura Dougherty, Haeseon Lee, Rebekah Gutowski, Manish Kohli. "Cost effectiveness of eight first-line regimens in metastatic hormone-sensitive prostate cancer (mHSPC) including niraparib + abiraterone acetate/prednisone.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.7_suppl.47